TABLE 3 Secondary outcomes
Secondary outcomes | Type of research | Research number | Sample | Heterogeneity test | Statistic effect model | 95%CI | P-value | |
|---|---|---|---|---|---|---|---|---|
P-value | I2/% | |||||||
Fracture healing time (month) | RCT | – | – | – | – | – | – | – |
non-RCT | 6(21–25,32) | 291 | 0.59 | 0% | MD (Fixed, 95% CI) | − 0.24 [− 0.47, 0.00] | 0.05 | |
Total drilling times (number) | RCT | 2(20,30) | 138 | 0.0006 | 92% | SMD (Random, 95% CI) | − 6.13 [− 9.35,− 2.90 | 0.0002 |
non− RCT | 6(21,22,25,31–33) | 274 | < 0.00001 | 92% | SMD (Random, 95% CI) | − 3.09 [− 4.38,− 1.80] | < 0.00001 | |
Fluoroscopy frequency (number) | RCT | 2(20,30) | 138 | 0.13 | 56% | SMD (Random, 95% CI) | − 6.64 [− 8.06,− 5.21] | < 0.00001 |
non− RCT | 10(4,21,22,24,25,28,29,31,33,34) | 620 | < 0.00001 | 91% | SMD (Random, 95% CI) | − 2.61 [− 3.40,− 1.82] | < 0.00001 | |